Will Morgan Stanley's named Section 16 officers conduct additional discretionary open-market sales exceeding $10M in aggregate during Q2 2026?

The January 2026 cluster was a clear pattern of coordinated post-earnings window discretionary selling. PSU vesting in Q2 creates fresh tranches to sell. The culture allows discretionary sales. Counter: governance optics after the Jan cluster will be scrutinized. The $10M threshold is modest given Jan was $25M+. Lean YES at 65%.

The pattern is established but stock has declined 13% from the January peak, reducing the attractiveness of another cluster at current prices. Executives may wait for stock to recover toward $180+ before selling again. However, Q2 window opens post-Q1 earnings and vesting cycles continue. Lean YES at 60%.

The $10M threshold is absolute not incremental, so it requires meaningful aggregate selling in Q2. Given the Jan cluster at $25M, repeating it or hitting $10M specifically is plausible. The governance scrutiny factor pushes probability down somewhat. Net around 58%.

The Jan 2026 pattern strongly favors YES. Stock recovery toward $170-180 range would make Q2 window attractive. $10M is achievable if even 4-5 executives sell at typical discretionary sizes.

Strong precedent plus predictable vesting plus modest threshold. Lean YES at 65%. The governance optics concern is real but the pattern was already public for Q1 and did not stop the cluster.

The Jan precedent is clear but Q2 may see adjustment toward 10b5-1 plans instead of discretionary. The resolution criteria exclude 10b5-1, which materially reduces the probability of hitting $10M in discretionary alone. Lean YES at 60% but with uncertainty about the 10b5-1 substitution.

Lean YES at 62%. Strong Jan precedent plus vesting cycles.

Lean YES given precedent but the stock decline and governance scrutiny create modest headwinds. 60%.

The pattern is too strong to discount. $10M is modest. Lean YES at 65%.